-
Recent Posts
- An integrated in silico pipeline identifies a novel TF combination that promotes enhanced CST growth following injury
- Spike timing-dependent plasticity in the adult rat with chronic cervical spinal cord contusion
- Effect of PTEN antagonist peptide on the functional motor recovery in rat
- GDF10 promotes axonal regeneration and functional recovery: A novel gene therapy strategy for spinal cord injury
- GTX Medical and NeuroRecovery Technologies to merge
- Candidate Therapy From Quebec for Chronic SCI Being Developed in Parallel by Academics and Companies in Switzerland and the Netherlands
- Moving beyond the glial scar for spinal cord repair
- The Struggle to Make CNS Axons Regenerate: Why Has It Been so Difficult?
- The potential of electric field for promoting neurite guidance in spinal cord injury regeneration strategies
- Extraction and selective activation of muscle synergies through spinal stimulation for SCI
- Early limb unloading elicits long-term motor deficits involving motorneuron hyperexcitability associated with persistent alterations in glutamatergic synaptic plasticity in spinal cord injury
- The effects of a pro-angiogenic, RGD-functionalized, nanofiber composite biomaterial on mesenchymal stem cell-mediated repair of the injured spinal cord
- From wheelchair to walking after spinal cord injury
- ReNetX Bio, Inc. Announces U.S. FDA Authorization to Proceed for IND Application to Treat Patients with Chronic Spinal Cord Injury
- Regeneration of Spinal Cord Connectivity Through Stem Cell Transplantation and Biomaterial Scaffolds
Follow on Twitter
My TweetsSpinal Cord Injury Research and Science at Facebook
Categories
Archives
Tag Archives: Dr. Jerry Silver
NervGen looking to use their technology to revolutionize nerve damage treatment
NervGen Pharma (CVE:NGEN) President and CEO Ernest Wong sat down with Steve Darling from Proactive Investors Vancouver to talk about the pharma company that has technology that hopes to regenerate nerve damage, that damage can be spinal cord or peripheral. … Continue reading
NERVGEN PHARMA COMPLETES $10 MILLION INITIAL PUBLIC OFFERING
Vancouver, Canada. March 13, 2019 – NervGen Pharma Corp. (“NervGen” or the “Company”), a regenerative medicine company dedicated to creating innovative solutions for the treatment of nerve damage, today announced that it has completed its initial public offering (“IPO”) of … Continue reading
Dr Jerry Silver – Spinal Cord Damage and Emerging Treatments
“Injuries to the spinal cord can cause permanent paralysis and even lead to death, with little to no hope of regaining lost functions once the trauma has occurred. Dr Jerry Silver and his team at Case Western Reserve University Medical … Continue reading
Case Western Reserve Researchers Restore Breathing and Partial Forelimb Function in Rats with Chronic Spinal Cord Injuries
Promising results provide hope for humans suffering from chronic paralysis “Millions of people worldwide are living with chronic spinal cord injuries, with 250,000 to 500,000 new cases each year—most from vehicle crashes or falls. The most severe spinal cord injuries … Continue reading
Worldwide licensing agreement made on peptide developed in Silver laboratory at Case Western Reserve University
Read the Full Article at Globe Newswire. VANCOUVER, British Columbia, July 18, 2018 (GLOBE NEWSWIRE) — NervGen Pharma Corp. (“NervGen”), in Vancouver, and Case Western Reserve University (“Case Western Reserve”) in Cleveland have entered into an exclusive worldwide licensing agreement to research, develop and … Continue reading
Modulation of Receptor Protein Tyrosine Phosphatase Sigma Increases Chondroitin Sulfate Proteoglycan Degradation through Cathepsin B Secretion to Enhance Axon Outgrowth
Authors: Amanda Phuong Tran, Sapna Sundar, Meigen Yu, Bradley T. Lang and Jerry Silver Abstract: Severed axon tips reform growth cones following spinal cord injury that fail to regenerate, in part, because they become embedded within an inhibitory extracellular matrix. … Continue reading
Rapid and robust recovery of breathing 1.5 years after cervical spinal cord injury
Methods to restore respiratory function following chronic cervical spinal cord injury (SCI) have not been extensively studied. This represents a major gap in our current understanding as the primary cause of morbidity and mortality following cervical SCI is respiratory motor … Continue reading
APPRAISAL AND RESTORATION OF RESPIRATORY FUNCTION FOLLOWING ACUTE AND CHRONIC SPINAL CORD TRAUMA
APPRAISAL AND RESTORATION OF RESPIRATORY FUNCTION FOLLOWING ACUTE AND CHRONIC SPINAL CORD TRAUMA Cervical spinal cord injury typically causes robust detrimental effects to respiratory motor function. We provide evidence demonstrating that these profound effects persist from acute to chronic time … Continue reading
CONTROL OF DIAPHRAGM ACTIVITY AFTER SCI IN THE ABSENCE OF SUPRASPINAL INPUT: THE CONTRIBUTION OF INTERNEURONS
CONTROL OF DIAPHRAGM ACTIVITY AFTER SCI IN THE ABSENCE OF SUPRASPINAL INPUT: THE CONTRIBUTION OF INTERNEURONS Respiratory drive is relayed to phrenic motor neurons via bulbospinal projections. Spinal cord injury at or above cervical level 4 disrupts these descending projections … Continue reading
Posted in Regenerative Medicine, spinal cord injury research
Tagged Dr. Jerry Silver, Jared Cregg, LT Landmesser
